$19.20
N/A
Ult. Agg.: Oct 22, 4:00 PM
$19.20
N/A
ArriVent BioPharma (AVBP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.98 | $-0.89 | $-0.86 | $-0.78 |
| Actual | $-1.05 | $-0.96 | $-0.78 | $-0.83 |
| Surprise | -7.14% | -7.87% | +9.30% | -6.41% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.06 | $-1.08 | $-0.93 | $-0.93 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-1.05 | $-0.98 | -7.14 % |
| Q1 | May 11, 2026 | $-0.96 | $-0.89 | -7.87 % |
| Q4 | Mar 5, 2026 | $-0.78 | $-0.86 | 9.30 % |
| Q3 | Nov 10, 2025 | $-0.83 | $-0.78 | -6.41 % |